Related Experiment Video
Updated: Jun 27, 2026
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
Maternal serum Apelin 13 and APLN gene promoter variant -1860T > C in preeclampsia
Rajeev Gandham1, C D Dayanand1, S R Sheela2
1Department of Biochemistry, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research (SDUAHER), Kolar, India.
Insights
Preeclamptic women exhibit lower serum apelin 13 levels and a higher frequency of the CC genotype and C allele in the APLN gene polymorphism. This finding suggests a potential link to cardiovascular complications post-delivery.
Area of Science:
- Reproductive Medicine
- Genetics
- Biochemistry
Background:
- Preeclampsia is a pregnancy complication characterized by high blood pressure and potential organ damage.
- Apelin, a peptide hormone, plays a role in cardiovascular regulation.
- The apelin gene (APLN) and its polymorphisms may influence preeclampsia risk and severity.
Purpose of the Study:
- To investigate the association between the APLN -1860 T>C polymorphism and maternal serum apelin 13 levels in preeclampsia.
- To explore the relationship between these factors and blood pressure in preeclamptic women.
Main Methods:
- A case-control study involving 181 pregnant women (91 with preeclampsia, 90 healthy controls).
- Analysis of APLN gene -1860 T>C polymorphism using molecular methods.
- Quantification of maternal serum apelin 13 levels via ELISA.
- Measurement of blood pressure, birth weight, and urinary protein.
Main Results:
- Preeclamptic women showed significantly higher blood pressure and lower birth weight compared to controls.
- Maternal serum apelin 13 concentrations were significantly lower in preeclampsia and negatively correlated with blood pressure.
- The CC genotype and C allele of the APLN -1860 T>C polymorphism were significantly more frequent in preeclamptic women.
Conclusions:
- Preeclamptic women have reduced serum apelin 13 levels and an increased prevalence of the CC genotype and C allele at the APLN gene promoter.
- These findings suggest a potential genetic and hormonal link to preeclampsia and may indicate a predisposition to later cardiac complications.
Objective:
To evaluate the apelin (APLN) -1860 T > C (rs56204867) polymorphism and maternal serum apelin 13 levels in preeclampsia and its association with blood pressure.
Methods:
This case-control study was conducted in department of Biochemistry, Sri Devaraj Urs Medical College, Karnataka, India. A total of 181 subjects were enrolled in the study from department of Department of Obstetrics and Gynecology. The recruited women were grouped as: Group-I (n = 91) cases with preeclampsia and Group-II (n = 90) normotensive healthy pregnant women as controls. Under aseptic conditions, the collected 5 mL blood was distributed for serum separation (3 mL) and genetic analysis (2 mL). Serum was stored at -80 °C after centrifugation at 3000 rpm for 10 min. The collected five mL urine sample was used for urinary protein analysis by dipstick method. The APLN gene -1860 T > C polymorphism and Apelin 13 levels were analyzed by molecular methods and ELISA technique respectively. Birth weight and demographic details were recorded.
Results:
In the present study, no significant difference was observed for mean gestational age and maternal age. Systolic (158.7 ± 14.0 mmHg) and diastolic (104.9 ± 10.7 mmHg) blood pressure, and mean arterial pressure (MAP) (123.0 ± 11.1 mmHg) (p-value .001) were significantly increased in preeclamptic women compared with healthy pregnant women. Birth weight (2.4 ± 0.5 kg) (p-value .001) was significantly decreased in babies born to preeclamptic mothers. Birth weights were also expressed in centiles, according to Fenton Chart. Number of small for gestational age (SGA) babies were more in preeclampsia (n = 55) than healthy pregnant women (n = 28). Mean maternal serum apelin 13 (239.4 ± 126.3 pg/mL) (p-value .001) concentrations were significantly lower in preeclampsia compared with healthy controls. Maternal serum apelin 13 concentration in preeclampsia was negatively correlated with systolic blood pressure (r = -0.235), diastolic blood pressure (r= -0.172) and mean arterial pressure (r = -0. 206). However, maternal serum apelin 13 levels showed insignificant positive correlation with age, gestational age and birth weight. The genotype and allele frequencies of APLN gene were found significant between study groups as in preeclampsia (χ2 = 11.69; df = 2; p = .0028 and χ2 = 14.27; df = 1; p = .00013 respectively). CC genotype and C allele of APLN - 1860 T > C site was high in preeclampsia.
Conclusion:
Study concludes that preeclamptic women have low level of serum apelin 13 and -1860 T > C polymorphism at APLN gene promoter site with increased allelic frequency of CC genotype and C allele compared to normotensive pregnant women. And this evidence may link to cardiac complications in preeclamptic women after delivery in later stage.
More Related Videos
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
05:30Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
